Evidence for Genetic Risk Contributing to Long-Term Adverse Treatment Effects in Childhood Cancer Survivors
View abstract on PubMed
Summary
This summary is machine-generated.Genetic factors significantly influence the risk of late effects in childhood cancer survivors. Incorporating genetic testing into risk prediction models can personalize survivor care plans.
Area Of Science
- Oncology
- Genetics
- Pediatric Medicine
Background
- Childhood cancer survivors face elevated risks of long-term health issues and mortality.
- While clinical and demographic factors for late effects are known, genetic influences are less understood.
Purpose Of The Study
- To review genetic modifiers impacting the risk of late effects from childhood cancer therapy.
- To highlight the need for integrating genetic risk into current prediction models.
Main Methods
- Literature review of existing studies on genetic risk factors for late effects.
- Analysis of recent research on genetic modifiers in childhood cancer survivors.
Main Results
- Genetic predisposition plays a role in the development of specific late effects.
- Current risk prediction models primarily rely on clinical and demographic data.
Conclusions
- Further clinical trials are needed to validate and incorporate genetic testing into risk prediction algorithms.
- Confirming genetic predisposition can enable individualized survivor care and therapeutic modifications early in treatment.